Umeå University's logo

umu.sePublications
Change search
CiteExportLink to record
Permanent link

Direct link
Cite
Citation style
  • apa
  • ieee
  • vancouver
  • Other style
More styles
Language
  • de-DE
  • en-GB
  • en-US
  • fi-FI
  • nn-NO
  • nn-NB
  • sv-SE
  • Other locale
More languages
Output format
  • html
  • text
  • asciidoc
  • rtf
Adult work ability following diagnosis of bacterial meningitis in childhood
Outcomes Research, Merck & Co, Inc, NJ, Rahway, United States.
Umeå University, Faculty of Medicine, Department of Clinical Microbiology.ORCID iD: 0000-0001-9885-2321
Umeå University, Faculty of Medicine, Department of Clinical Sciences, Paediatrics.ORCID iD: 0000-0002-3606-3797
Outcomes Research, Stockholm, Sweden.
Show others and affiliations
2024 (English)In: JAMA Network Open, E-ISSN 2574-3805, Vol. 7, no 12, article id e2445497Article in journal (Refereed) Published
Abstract [en]

Importance: A diagnosis of bacterial meningitis in childhood can lead to permanent neurological disabilities. Few studies have examined long-term consequences for work ability in adulthood.

Objective: To compare earnings, work loss, and educational attainment between adults diagnosed with bacterial meningitis in childhood and population comparators.

Design, Setting, and Participants: This nationwide registry-based matched cohort study included individuals in Sweden diagnosed with bacterial meningitis in childhood (aged <18 years) from January 1, 1987, to December 31, 2019, and general population comparators matched 1:9 on age, sex, and place of residence. Follow-up was completed December 31, 2020. Data were analyzed from February 7 to September 12, 2023.

Exposure: A diagnosis of bacterial meningitis in childhood recorded in the National Patient Register.

Main Outcomes and Measures: Annual taxable earnings (in 2020 US dollars), work loss (sum of sick leave and disability insurance), and educational attainment.

Results: The cohort included 2534 individuals diagnosed with bacterial meningitis in childhood (mean [SD] age at diagnosis, 4.7 [5.3] years) and 22 806 comparators (13 510 [53.3%] male). Among those with childhood bacterial meningitis, 812 (32.0%) were diagnosed at younger than 1 year and 1351 (53.3%) were male. From 18 to 34 years of age, those with childhood meningitis had lower adjusted earnings relative to comparators and higher adjusted work loss. When pooling observations for individuals 28 years or older, the annual mean reduction in earnings was -$1295 (95% CI, -$2587 to -$4), representing a 4.0% (95% CI, 0%-8.0%) reduction relative to comparators, and the annual increase in work loss was 13.5 (95% CI, 8.6-18.5) days. There was a larger reduction in earnings for those with childhood meningitis relative to comparators with pneumococcal (Streptococcus pneumoniae) vs meningococcal (Neisseria meningitidis) meningitis. For work loss, there was a difference among all 3 major causes of meningitis, with the largest increase for pneumococcal meningitis. Individuals diagnosed at a younger age (below the median) had lower earnings relative to comparators and higher work loss than individuals diagnosed at an older age (above the median). Fewer individuals with childhood meningitis relative to comparators had obtained a high school degree at age 30 years (adjusted odds ratio, 0.68 [95% CI, 0.56-0.81]).

Conclusions and Relevance: In this cohort study of adults diagnosed with bacterial meningitis in childhood, findings suggest that work ability decreases relative to population comparators, with lower earnings and higher work loss, especially among adults diagnosed with pneumococcal meningitis or diagnosed at a young age, with long-lasting costs for the individual patient and society at large.

Place, publisher, year, edition, pages
American Medical Association (AMA), 2024. Vol. 7, no 12, article id e2445497
National Category
Pediatrics Occupational Health and Environmental Health
Identifiers
URN: urn:nbn:se:umu:diva-233784DOI: 10.1001/jamanetworkopen.2024.45497ISI: 001373815000003PubMedID: 39621349Scopus ID: 2-s2.0-85211408581OAI: oai:DiVA.org:umu-233784DiVA, id: diva2:1925746
Conference
13th Meeting of the International Society of Pneumonia and Pneumococcal Diseases, Cape Town, South Africa, March 17-20, 2024
Note

This paper was presented in part at the 13th Meeting of the International Society of Pneumonia and Pneumococcal Diseases; March 17 to 20, 2024; Cape Town, South Africa.

Available from: 2025-01-09 Created: 2025-01-09 Last updated: 2025-03-26Bibliographically approved

Open Access in DiVA

fulltext(1127 kB)18 downloads
File information
File name FULLTEXT01.pdfFile size 1127 kBChecksum SHA-512
90d3461ffde0cd2d95b8af7fc58cb406e3587e15a832f474c49c577aa5f0b6ad63aadaddc0d96418f9f0a960343b02eea3cea5db06258f06c39b6f29f9451a4f
Type fulltextMimetype application/pdf

Other links

Publisher's full textPubMedScopus

Authority records

Johansson Kostenniemi, UrbanSilfverdal, Sven-Arne

Search in DiVA

By author/editor
Johansson Kostenniemi, UrbanSilfverdal, Sven-Arne
By organisation
Department of Clinical MicrobiologyPaediatrics
In the same journal
JAMA Network Open
PediatricsOccupational Health and Environmental Health

Search outside of DiVA

GoogleGoogle Scholar
Total: 18 downloads
The number of downloads is the sum of all downloads of full texts. It may include eg previous versions that are now no longer available

doi
pubmed
urn-nbn

Altmetric score

doi
pubmed
urn-nbn
Total: 297 hits
CiteExportLink to record
Permanent link

Direct link
Cite
Citation style
  • apa
  • ieee
  • vancouver
  • Other style
More styles
Language
  • de-DE
  • en-GB
  • en-US
  • fi-FI
  • nn-NO
  • nn-NB
  • sv-SE
  • Other locale
More languages
Output format
  • html
  • text
  • asciidoc
  • rtf